Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01544062 · ClinicalTrials.gov registry record · Phase 4
IV Acetaminophen as an Adjunct Analgesic in Cardiac Surgery
A Phase 4 study, sponsored by University of Washington.
- Completed
- Registry status
- Phase 4
- Development phase
- 68
- Enrollment target
NCT01544062 is a Phase 4 study that has completed, run by University of Washington. The registered enrollment target is 68 participants.
The verdict
NCT01544062, a Phase 4 study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 68 participants
- Enrollment target
Study Summary
Patients undergoing cardiac surgery experience significant postoperative pain, which may impact postoperative outcomes. The aim of this single center, double-blind, randomized, placebo controlled trial is to determine if intravenous (IV) acetaminophen will significantly decrease 24 hour postoperative opioid consumption.
Interventions
- DRUG Placebo
- DRUG IV acetaminophen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68 participants |
| Start Date | 2012-07 |
| Est. Completion | 2014-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01544062
The ClinicalTrials.gov registry entry for NCT01544062 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 68 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01544062 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01544062 about?
NCT01544062 is a clinical study titled "IV Acetaminophen as an Adjunct Analgesic in Cardiac Surgery". Patients undergoing cardiac surgery experience significant postoperative pain, which may impact postoperative outcomes. The aim of this single center, double-blind, randomized, placebo controlled trial is to determine if intravenous (IV) acetaminophen will significantly decrease 24 hour postoperativ...
What is the current status of trial NCT01544062?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 68 participants. The study started on 2012-07. Estimated completion is 2014-08.
What interventions are being tested in trial NCT01544062?
The interventions under investigation include: Placebo (DRUG), IV acetaminophen (DRUG).
Who is sponsoring clinical trial NCT01544062?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.